| |
|
United States Dollar |
|
| |
Figures in millions unless otherwise stated |
|
2017 |
2016 |
|
| 28. |
TRADE AND OTHER PAYABLES |
|
|
|
|
|
|
| |
(Loss)/profit from continuing operations |
(344.8) |
|
|
(20.8) |
167.9 |
|
| |
Mining and income taxation |
(65.9) |
|
|
173.2 |
189.5 |
|
| |
Royalties |
62.5 |
|
|
62.0 |
78.4 |
|
| |
Interest expense |
91.8 |
|
|
91.2 |
82.5 |
|
| |
Interest received |
(6.8) |
|
|
(5.1) |
(7.3) |
|
| |
Amortisation and depreciation |
668.4 |
|
|
748.1 |
671.4 |
|
| |
Interest expense – environmental rehabilitation |
11.7 |
|
|
12.1 |
10.7 |
|
| |
Non-cash rehabilitation income |
(0.9) |
|
|
(13.5) |
(9.7) |
|
| |
Interest received – environmental trust funds |
(0.6) |
|
|
(0.5) |
|
|
| |
Impairment, net of reversal of impairment of investments and assets |
520.3 |
|
|
200.2 |
76.5 |
|
| |
Write-off of exploration and evaluation assets |
37.7 |
|
|
51.5 |
41.4 |
|
| |
Loss/(profit) on disposal of assets |
51.6 |
|
|
(4.0) |
(48.0) |
|
| |
Profit on disposal of investments |
– |
|
|
– |
(2.3) |
|
| |
Gain on acquisition of Asanko |
(51.8) |
|
|
– |
– |
|
| |
Unrealised loss/(gain) on derivative contracts2 |
36.6 |
|
|
(20.7) |
(14.4) |
|
| |
Fair value (gain)/loss on Maverix warrants2 |
(3.8) |
|
|
0.4 |
– |
|
| |
Profit on dilution of Gold Fields’ interest in Maverix |
(4.0) |
|
|
– |
– |
|
| |
Silicosis settlement costs2 |
(4.5) |
|
|
30.2 |
|
|
| |
Share-based payments |
37.5 |
|
|
26.8 |
14.0 |
|
| |
Long-term incentive plan expense |
1.1 |
|
|
5.0 |
10.5 |
|
| |
Payment of long-term incentive plan |
(17.8) |
|
|
(11.5) |
– |
|
| |
Borrowing costs capitalised |
(17.5) |
|
|
(22.9) |
(15.1) |
|
| |
Share of results of equity accounted investees, net of taxation |
0.2 |
|
|
(0.3) |
– |
|
| |
Other2 |
(3.0) |
|
|
(14.9) |
0.4 |
|
| |
Total cash generated by operations |
998.0 |
|
|
1,286.5 |
1,245.4 |
|